Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran

Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran

Abstract Background No research has assessed the comprehensive annual costs of managing ulcerative colitis (UC) patients undergoing biological treatment. This study aimed to determine the annual costs and primary cost drivers for UC patients receiving biological therapy. Methods This prospective obs...

Full description

Saved in:
Bibliographic Details
Main Authors: Hassan Karami, Amin Ghanbarnejad, Mitra Nowrouzpour, Ali Mouseli, Reihaneh Taheri Kondar, Maryam Shirvani Shiri, Farbod Ebadi Fard Azar
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Health Services Research
Subjects:
Ulcerative colitis
Cost of illness
Economic burden
Direct costs
Indirect costs
Online Access:https://doi.org/10.1186/s12913-025-12474-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12913-025-12474-6

Similar Items